Public Health Emergency - Leading a Nation Prepared
BARDA is continuing to work with its partners to identify promising medical countermeasures and technologies to combat the 2019 novel coronavirus. Now, there are three ways your company or organization can partner with BARDA to fight the ongoing novel coronavirus outbreak.
BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003). Specifically, BARDA is pursuing the following products or technologies:
To learn more, including targets for product maturity under this announcement, see the newly revised
BARDA Broad Agency Announcement.
To spur innovation, BARDA has issued its business-friendly, streamlined Easy Broad Agency Announcement (EZ-BAA) to support a number of new medical countermeasures to fight the COVID-19 outbreak. Under the EZ-BAA, BARDA is looking for:
To learn more, see the
Novel Coronavirus EZ-BAA.
If you are interested in partnering with the federal government on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners! The federal government established a single point of entry for product developers to submit their research on 2019 novel coronavirus medical countermeasures. Submit a brief description and supporting materials through our
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages